# Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases

> **NCT07348588** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Centro de Pesquisa Rubens Siqueira** · enrollment: 30 (estimated)

## Conditions studied

- Retinitis Pigmentosa (RP)
- Extensive Macular Atrophy With Pseudodrusen (EMAP)

## Interventions

- **DRUG:** Intravitreal Adalimumab

## Key facts

- **NCT ID:** NCT07348588
- **Lead sponsor:** Centro de Pesquisa Rubens Siqueira
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2025-08-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07348588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07348588, "Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07348588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*